Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis Trials

Armstrong AW, Kircik L, Stein Gold L, Strober B, De Oliveira CHMC, Vaile J, Jou YM, Daamen C, Scharnitz T, Lebwohl M. Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis Trials. Dermatol Ther (Heidelb). 2025 Mar 20. doi: 10.1007/s13555-025-01362-w. Epub ahead of print. PMID: 40113724.


Related Posts